Urinary tract infection in women: New pathogenic considerations

Current Infectious Disease Reports

Volumn 8, Issue 6, 2006, Pages 465-472

  Stapleton, Ann E ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 O METHYLGALACTOSE; ADHESIN; BACTERIAL TOXIN; CHEMOKINE RECEPTOR CXCR1; CIPROFLOXACIN; CRANBERRY EXTRACT; FIMBRIA PROTEIN; IRON REGULATED GENE HOMOLOGUE ADHESIN; MEMBRANE PROTEIN; PHLORIZIN; PROBIOTIC AGENT; PRUNIN; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; BACTERIAL GENE; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; CHILDHOOD DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; CRANBERRY JUICE; CYSTITIS; DOSE RESPONSE; DRUG EFFICACY; ESCHERICHIA COLI; FEMALE; GENE SEQUENCE; GENETIC RECOMBINATION; HETEROZYGOSITY; HOST SUSCEPTIBILITY; HUMAN; INCIDENCE; INFECTION RISK; INNATE IMMUNITY; INTERMETHOD COMPARISON; LACTOBACILLUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PATHOGENICITY ISLAND; PHYLOGENETIC TREE; POLYMERASE CHAIN REACTION; PREMENOPAUSE; PREVALENCE; PULSED FIELD GEL ELECTROPHORESIS; PYELONEPHRITIS; RECEPTOR BINDING; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEQUENCE ALIGNMENT; SEX DIFFERENCE; SIGNAL TRANSDUCTION; URINARY TRACT INFECTION; WOMEN'S HEALTH;

EID: 33750919291     PISSN: 15233847     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11908-006-0021-9     Document Type: Review

References (69)

1. Hooton T: The current management strategies for community-acquired urinary tract infection. Infect Dis Clin North Am 2003, 17:303-332.
2. Bent S, Nallamothu BK, Simel DL, et al.: Does this woman have an acute uncomplicated urinary tract infection? JAMA 2002, 287:2701-2710.
3. Hooton TM, Scholes D, Hughes JP, et al.: A prospective study of risk factors for symptomatic urinary tract infection in young women. N Engl J Med 1996, 335:468-474. [Published comments appear in N Engl J Med 1996, 335:511-512 and N Engl J Med 1997, 336:381; author reply 381-382.]
4. Foxman B, Barlow R, D'Arcy H, et al.: Urinary tract infection. self-reported incidence and associated costs. Ann Epidemiol 2000, 10:509-515.
5. Ronald A, Harding G: Complicated urinary tract infections. Infect Dis Clin North Am 1997, 11:583-592.
6. Ferri C, Marchetti F, Nickel JC, Naber KG: Prevalence and clinical management of complicated urinary tract infections in Italy: a prospective multicenter epidemiological study in urological outpatients. J Chemother 2005, 17:601-606.
7. Hooton TM, Scholes D, Stapleton AE, et al.: A prospective study of asymptomatic bacteriuria in sexually active young women. N Engl J Med 2000, 343:992-997. [Published comment appears in N Engl J Med 2000, 343:1037-1039.]
8. Johnson J: Microbial virulence determinants and the pathogenesis of urinary tract infection. Infect Dis Clin North Am 2003, 17:261-278, viii.
9. Johnson JR: Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev 1991, 4:80-128.
10. Roberts JA, Marklund BI, Ilver D, et al.: The Gal(alpha 1-4)Gal-specific tip adhesin of Escherichia coli P-fimbriae is needed for pyelonephritis to occur in the normal urinary tract. Proc Natl Acad Sci USA 1994, 91:11889-11893.
11. Winberg J, Mollby R, Bergstrom J, et al.: The PapG-adhesin at the tip of P-fimbriae provides Escherichia coli with a competitive edge in experimental bladder infections of cynomolgus monkeys. J Exp Med 1995, 182:1695-1702.
12. Leffler H, Svanborg-Eden C: Chemical identification of a glycosphingolipid receptor for Escherichia coli attaching to human urinary tract cells and agglutinating human erythrocytes. FEMS Microbiol Lett 1980, 8:127-134.
13. Leffler H, Svanborg-Eden C: Glycolipid receptors for uropathogenic Escherichia coli on human erythrocytes and uroepithelial cells. Infect Immun 1981, 34:920-929.
14. Leffler H, Lomberg H, Svanborg-Eden C: Glycolipid receptors for bacterial adhesion on human urinary tract epithelium: relation to blood group and age. In Host Parasite Interactions in Urinary Tract Infections. Edited by Kass EH, Svanborg-Eden C. Chicago, IL: University of Chicago Press; 1989:93-99.
15. Otto G, Burdick M, Strieter R, Godaly G: Chemokine response to febrile urinary tract infection. Kidney Int 2005, 68:62-70.
16. Hedlund M, Svensson M, Nilsson A, et al.: Role of the ceramide-signaling pathway in cytokine responses to P-fimbriated Escherichia coli. J Exp Med 1996, 183:1037-1044.
17. Hedlund M, Duan RD, Nilsson A, Svanborg C: Sphingomyelin, glycosphingolipids and ceramide signalling in cells exposed to P-fimbriated Escherichia coli. Mol Microbiol 1998, 29:1297-1306.
18. Hedlund M, Wachtler C, Johansson E, et al.: P fimbriae-dependent, lipopolysaccharide-independent activation of epithelial cytokine responses. Mol Microbiol 1999, 33:693-703.
19. Frendeus B, Wachtler C, Hedlund M, et al.: Escherichia coli P fimbriae utilize the Toll-like receptor 4 pathway for cell activation. Mol Microbiol 2001, 40:37-51.
20. Wullt B, Bergsten G, Carstensen J, et al.: Mucosal host responses to bacteriuria in colonic and ileal neobladders. Eur Urol 2006, Epub ahead of print.
21. Wullt B, Bergsten G, Connell H, et al.: P-fimbriae trigger mucosal responses to Escherichia coli in the human urinary tract. Cell Microbiol 2001, 3:255-264.
22. Jones CH, Pinkner JS, Roth R, et al.: FimH adhesin of type 1 pili is assembled into a fibrillar tip structure in the Enterobacteriaceae. Proc Natl Acad Sci USA 1995, 92:2081-2085.
23. Xu Z, Jones CH, Haslam D, et al.: Molecular dissection of PapD interaction with PapG reveals two chaperone-binding sites. Mol Microbiol 1995, 16:1011-1020.
24. Mulvey MA, Schilling JD, Martinez JJ, Hultgren SJ: Bad bugs and beleaguered bladders: interplay between uropathogenic Escherichia coli and innate host defenses. Proc Natl Acad Sci USA 2000, 97:8829-8835.
25. Mulvey MA, Hultgren SJ: Cell biology. Bacterial spelunkers. Science 2000, 289:732-733.
26. Justice SS, Hung C, Theriot JA, et al.: Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis. Proc Natl Acad Sci USA 2004, 101:1333-1338.
27. Eto DS, Sundsbak JL, Mulvey MA: Actin-gated intracellular growth and resurgence of uropathogenic Escherichia coli. Cell Microbiol 2006, 8:704-717.
28. Duncan MJ, Mann EL, Cohen MS, et al.: The distinct binding specificities exhibited by enterobacterial type 1 fimbriae are determined by their fimbrial shafts. J Biol Chem 2005, 280:37707-37716.
29. Das M, Hart-Van Tassell A, Urvil PT, et al.: Hydrophilic domain II of Escherichia coli Dr fimbriae facilitates cell invasion. Infect Immun 2005, 73:6119-6126.
30. Davis JM, Rasmussen SB, O'Brien AD: Cytotoxic necrotizing factor type 1 production by uropathogenic Escherichia coli modulates polymorphonuclear leukocyte function. Infect Immun 2005, 73:5301-5310.
31. Kouokam JC, Wai SN, Fallman M, et al.: Active cytotoxic necrotizing factor 1 associated with outer membrane vesicles from uropathogenic Escherichia coli. Infect Immun 2006, 74:2022-2030.
32. Tomenius H, Pernestig A-K, Jonas K, et al.: The Escherichia coli BarA-UvrY two-component system is a virulence determinant in the urinary tract. BMC Microbiol 2006, 6:27.
33. Johnson JR, Jelacic S, Schoening LM, et al.: The IrgA homologue adhesin Iha is an Escherichia coli virulence factor in murine urinary tract infection. Infect Immun 2005, 73:965-971.
34. Leveille S, Caza M, Johnson JR, et al.: Iha from an Escherichia coli urinary tract infection outbreak clonal group A strain is expressed in vivo in the mouse urinary tract and functions as a catecholate siderophore receptor. Infect Immun 2006, 74:3427-3436.
35. Lane MC, Lockatell V, Monterosso G, et al.: Role of motility in the colonization of uropathogenic Escherichia coli in the urinary tract. Infect Immun 2005, 73:7644-7656.
36. Wright KJ, Seed PC, Hultgren SJ: Uropathogenic Escherichia coli flagella aid in efficient urinary tract colonization. Infect Immun 2005, 73:7657-7668.
37. Bidet P, Bonacorsi S, Clermont O, et al.: Multiple insertional events, restricted by the genetic background, have led to acquisition of pathogenicity Island IIJ96-like domains among Escherichia coli strains of different clinical origins. Infect Immun 2005, 73:4081-4087.
38. Soto SM, Jimenez de Anta MT, Vila J: Quinolones induce partial or total loss of pathogenicity islands in uropathogenic Escherichia coli by SOS-dependent or -independent pathways, respectively. Antimicrob Agents Chemother 2006, 50:649-653.
39. Roos V, Klemm P: Global gene expression profiling of the asymptomatic bacteriuria Escherichia coli strain 83972 in the human urinary tract. Infect Immun 2006, 74:3565-3575.
40. Hull R, Rudy D, Donovan W, et al.: Urinary tract infection prophylaxis using Escherichia coli 83972 in spinal cord injured patients. J Urol 2000, 163:872-877.
41. Hull RA, Rudy DC, Donovan WH, et al.: Virulence properties of Escherichia coli 83972, a prototype strain associated with asymptomatic bacteriuria. Infect Immun 1999, 67:429-432.
42. Klemm P, Roos V, Ulett GC, et al.: Molecular characterization of the Escherichia coli asymptomatic bacteriuria Strain 83972: the taming of a pathogen. Infect Immun 2006, 74:781-785.
43. Roos V, Schembri MA, Ulett GC, Klemm P: Asymptomatic bacteriuria Escherichia coli strain 83972 carries mutations in the foc locus and is unable to express F1C fimbriae. Microbiology 2006, 152:1799-1806.
44. Bergsten G, Samuelsson M, Wullt B, et al.: PapG-dependent adherence breaks mucosal inertia and triggers the innate host response. J Infect Dis 2004, 189:1734-1742.
45. Holden NJ, Totsika M, Mahler E, et al.: Demonstration of regulatory cross-talk between P fimbriae and type 1 fimbriae in uropathogenic Escherichia coli. Microbiology 2006, 152:1143-1153.
46. Snyder JA, Haugen BJ, Lockatell CV, et al.: Coordinate expression of fimbriae in uropathogenic Escherichia coli. Infect Immun 2005, 73:7588-7596.
47. Roos V, Ulett GC, Schembri MA, Klemm P: The asymptomatic bacteriuria Escherichia coli strain 83972 outcompetes uropathogenic E. coli strains in human urine. Infect Immun 2006, 74:615-624.
48. Godaly G, Bergsten G, Hang L, et al.: Neutrophil recruitment, chemokine receptors, and resistance to mucosal infection. J Leukoc Biol 2001, 69:899-906.
49. Smithson A, Sarrias MR, Barcelo J, et al.: Expression of interleukin-8 receptors (CXCR1 and CXCR2) in premenopausal women with recurrent urinary tract infections. Clin Diagn Lab Immunol 2005,12:1358-1363.
50. Benfield TL, Dahl M, Nordestgaard BG, Tybjaerg-Hansen A: Influence of the Factor V Leiden mutation on infectious disease susceptibility and outcome: A population-based study. J Infect Dis 2005, 192:1851-1857.
51. Hunstad DA, Justice SS, Hung CS, et al.: Suppression of bladder epithelial cytokine responses by uropathogenic Escherichia coli. Infect Immun 2005, 73:3999-4006.
52. Patole PS, Schubert S, Hildinger K, et al.: Toll-like receptor-4: Renal cells and bone marrow cells signal for neutrophil recruitment during pyelonephritis. Kidney Int 2005, 68:2582-2587.
53. Sadeghi M, Daniel V, Naujokat C, et al.: Strikingly higher interleukin (IL)-1alpha, IL-1beta and soluble interleukin-1 receptor antagonist (sIL-1RA) but similar EL-2, sIL-2R, IL-3, IL-4, IL-6, sIL-6R, IL-10, tumour necrosis factor (TNF)-alpha, transforming growth factor (TGF)-beta2 and interferon IFN-gamma urine levels in healthy females compared to healthy males: protection against urinary tract injury? Clin and Exper Immun 2005, 142:312-317.
54. Meyer-Siegler KL, Iczkowski KA, Vera PL: Macrophage migration inhibitory factor is increased in the urine of patients with urinary tract infection: Macrophage migration inhibitory factor-protein complexes in human urine. J Urol 2006, 175:1523-1528.
55. Tartof SY, Solberg OD, Manges AR, Riley LW: Analysis of a uropathogenic Escherichia coli clonal group by multilocus sequence typing. J Clin Microbiol 2005, 43:5860-5864.
56. Redondo-Lopez V, Cook RL, Sobel JD: Emerging role of lactobacilli in the control and maintenance of the vaginal microflora. Rev Infect Dis 1990, 12:856-872.
57. Antonio MA, Hawes SE, Hillier SL: The identification of vaginal Lactobacillus species and the demographic and microbiologic characteristics of women colonized by these species. J Infect Dis 1999, 180:1950-1956.
58. Gupta K, Hillier SL, Hooton TM, et al.: Effects of contraceptive method on the vaginal microbial flora: a prospective evaluation. J Infect Dis 2000, 181:595-601.
59. Gupta K, Stapleton AE, Hooton TM, et al.: Inverse association of H202-producing lactobacilli and vaginal Escherichia coli colonization in women with recurrent urinary tract infections. J Infect Dis 1998, 178:446-450.
60. Hawes SE, Hillier SL, Benedetti J, et al.: Hydrogen peroxide-producing lactobacilli and acquisition of vaginal infections. J Infect Dis 1996, 174:1058-1063.
61. Atassi F, Brassart D, Grob P, et al.: Vaginal Lactobacillus isolates inhibit uropathogenic Escherichia coli. FEMS Microbiol Lett 2006, 257:132-138.
62. Kwok L, Stapleton AE, Stamm WE, et al.: Adherence of Lactobacillus crispatus to vaginal epithelial cells from women with and without a history of recurrent UTI. J Urol 2006, In press.
63. Jepson RG, Mihaljevic L, Craig J: Cranberries for preventing urinary tract infections. Cochrane Database Syst Rev 2001, 3: CD001321.
64. Howell AB, Vorsa N, Der Marderosian A, Foo L: Inhibition of the adherence of P-fimbriated Escherichia coli to uroepithelial-cell surfaces by proanthocyanidin extracts from cranberries. N Engl J Med 1998, 339:1085-1086.
65. Foo L, Lu Y, Howell AB, Vorsa N: A-type proanthocyanidin trimers from cranbery that inhibit adherence of uropathogenic P-fimbriated Eschericha coli. J Nat Prods 2000, 63:1225-1229.
66. Turner A, Chen SN, Joike MK, et al.: Inhibition of uropathogenic Escherichia coli by cranberry juice: a new antiadherence assay. J Agric Food Chem 2005, 53:8940-8947.
67. Di Martino P, Agniel R, David K, et al.: Reduction of Escherichia coli adherence to uroepithelial bladder cells after consumption of cranberry juice: a double-blind randomized placebo-controlled cross-over trial. World J Urol 2006, 24:21-27.
68. Greenberg JA, Newmann SJ, Howell AB: Consumption of sweetened dried cranberries versus unsweetened raisins for inhibition of uropathogenic Escherichia coli adhesion in human urine: A pilot study. J Altern Complement Med 2005, 11:875-878.
69. Chen SL, Hung C-S, Xu J, et al.: Identification of genes subject to positive selection in uropathogenic strains of Escherichia coli: A comparative genomics approach. PNAS 2006, 103:5977-5982.